Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice Jordi Gratacós-Masmitja; Emma Beltrán Catalán; José Luis Álvarez Vega; Ana Urruticoechea-Arana; Concepción Fito; Francisco Maceiras; Joaquín María Belzunegui Otano; Julia Fernández Melón; Eugenio Chamizo Carmona; Miguel Ángel Abad Hernández; Inmaculada Ros Vilamajó; Sonia Castro Oreiro; Eva Pascual Alfonso; Juan Carlos Torre Alonso;

Drugs Recommended in Adult Rheumatic Diseases, But Considered for Off-Label Use in Argentina Fernando Villalobos; Carla Matellan; Gabriel Sequeira; Eduardo Kerzberg;

2021 clinical practice guideline for the early detection, diagnosis, treatment, and monitoring of patients with axial spondyloarthritis. Colombian Association of Rheumatology Wilson Bautista-Molano; Lina M. Saldarriaga-Rivera; Alejandro Junca-Ramírez; Andrés R. Fernández-Aldana; Daniel G. Fernández-Ávila; Diego A. Jaimes; Edwin A. Jauregui; Juan S. Segura-Charry; Consuelo Romero-Sanchez; Oscar J. Felipe-Diaz;